Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

604 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies.
Sonnichsen D, Dorer DJ, Cortes J, Talpaz M, Deininger MW, Shah NP, Kantarjian HM, Bixby D, Mauro MJ, Flinn IW, Litwin J, Turner CD, Haluska FG. Sonnichsen D, et al. Among authors: talpaz m. Cancer Chemother Pharmacol. 2013 Jun;71(6):1599-607. doi: 10.1007/s00280-013-2160-7. Epub 2013 Apr 23. Cancer Chemother Pharmacol. 2013. PMID: 23609479 Free PMC article. Clinical Trial.
Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
Kantarjian HM, Talpaz M, LeMaistre CF, Spinolo J, Spitzer G, Yau J, Dicke K, Jagannath S, Deisseroth AB. Kantarjian HM, et al. Among authors: talpaz m. Cancer. 1991 Jun 15;67(12):2959-65. doi: 10.1002/1097-0142(19910615)67:12<2959::aid-cncr2820671203>3.0.co;2-t. Cancer. 1991. PMID: 1675151
Therapy of chronic myelogenous leukemia with interferon.
Kurzrock R, Gutterman JU, Kantarjian H, Talpaz M. Kurzrock R, et al. Among authors: talpaz m. Cancer Invest. 1989;7(1):83-91. doi: 10.3109/07357908909038270. Cancer Invest. 1989. PMID: 2472193 No abstract available.
Characteristics of accelerated disease in chronic myelogenous leukemia.
Kantarjian HM, Dixon D, Keating MJ, Talpaz M, Walters RS, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: talpaz m. Cancer. 1988 Apr 1;61(7):1441-6. doi: 10.1002/1097-0142(19880401)61:7<1441::aid-cncr2820610727>3.0.co;2-c. Cancer. 1988. PMID: 3162181
604 results